CLINICAL TRIALS ON ALZHEIMER’S DISEASE (CTAD)
BARCELONA, SPAIN, NOVEMBER 5-7, 2015
Cultural adaptation of cognitive assessments improves the quality of translated
instruments by ensuring tasks, stimuli, and instructions are understood and are
appropriate for use in populations of interest. We present methods and results from a
comprehensive linguistic and cultural adaptation of the TOMMORROW
cognitive battery, designed to detect transition from normal aging to mild
cognitive impairment due to Alzheimer’s disease (MCI-AD) in multinational
clinical trials.